IRD · Opus Genetics, Inc. · Executive Compensation
$4.27
+0.34 (+8.65%)
At close · Nov 4
Return incl. dividend (before tax)
Market Cap
$326.96M
Shares
83.20M
Volume · Nov 4
1.16M
Avg daily vol (3M)
2.48M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Dr. George Magrath | Chief Executive Officer | $1,493,383 |
| Dr. Ashwath Jayagopal | Chief Scientific and Development Officer | $764,848 |
| Joseph Schachle | Chief Operating Officer | $718,408 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dr. Ashwath Jayagopal | Chief Scientific and Development Officer | $1,242,154 |
| Dr. George Magrath | Chief Executive Officer | $889,238 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mina Sooch | Former Chief Executive Officer and President | $2,811,138 |
| Dr. George Magrath | Chief Executive Officer | $2,667,353 |
| Richard Rodgers | Director and Former Interim Chief Executive Officer and President | $899,076 |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | $789,918 |
| Amy Rabourn | Senior Vice President of Finance | $789,918 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mina Sooch | Former Chief Executive Officer and President | $1,341,595 |
| Amy Rabourn | Senior Vice President of Finance | $499,267 |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | $446,496 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mina Sooch | Former Chief Executive Officer and President | $801,030 |
| Amy Rabourn | Vice President of Finance | $332,093 |
| Bernhard Hoffmann | Vice President of Corporate Development and Operations | $325,094 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Douglas J. Swirsky | Former President and Chief Executive Officer | $1,572,528 |
| Mina Sooch | Chief Executive Officer and President | $486,887 |
| Amy Rabourn | Vice President of Finance | $266,656 |
| Bernhard Hoffmann | Vice President of Corporate Development and Operations | $104,179 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Douglas J. Swirsky | Former President and Chief Executive Officer | $650,677 |
| Mina Sooch | Chief Executive Officer and President | — |
| Bernhard Hoffmann | Vice President of Corporate Development and Operations | — |
| Amy Rabourn | Vice President of Finance | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ashwath Jayagopal | Chief Scientific and Development Officer | Terminated | 2026-10-21 |
| Rob Gagnon | Chief Financial Officer | Appointed | 2025-09-02 |
| Robert Gagnon | Chief Financial Officer and principal accounting officer | Appointed | 2025-09-02 |
| Nirav Jhaveri | Chief Financial Officer | Terminated | 2025-06-25 |
| Dr. Adrienne Graves | members of the Board | Appointed | 2024-10-22 |
| Dr. Benjamin R. Yerxa | President | Appointed | 2024-10-22 |
| Dr. Benjamin R. Yerxa | members of the Board | Appointed | 2024-10-22 |
| Dr. Jean Bennett | members of the Board | Appointed | 2024-10-22 |
| Dr. Jay Pepose | the Board | Resigned | 2024-10-22 |
| Nirav Jhaveri | Chief Financial Officer | Appointed | 2024-02-16 |
| Ash Jayagopal | Chief Scientific and Development Officer | Appointed | 2024-02-16 |
| Nirav Jhaveri | Chief Financial Officer | Appointed | 2024-02-16 |
| Ronil A. Patel | Chief Business Officer | Appointed | 2023-12-06 |
| Ronil Patel | Chief Business Officer | Appointed | 2023-12-06 |
| Joseph K. Schachle | Chief Operating Officer | Appointed | 2023-11-27 |
| Joseph Schachle | Chief Operating Officer | Appointed | 2023-11-27 |
| George Magrath, M.D., M.B.A., M.S. | member of the Board of Directors | Appointed | 2023-11-01 |
| George Magrath, M.D., M.B.A., M.S. | Chief Executive Officer | Appointed | 2023-11-01 |
| Richard Rodgers | Interim President and Chief Executive Officer | Terminated | 2023-11-01 |
| George Magrath | member of the Board | Appointed | 2023-11-01 |
| George Magrath | Chief Executive Officer | Appointed | 2023-11-01 |
| Ms. Sooch | Chief Executive Officer | Terminated | 2023-06-14 |
| Richard Rodgers | interim President and Chief Executive Officer | Appointed | 2023-04-21 |
| Mina Sooch | President and Chief Executive Officer | Terminated | 2023-04-21 |
Leadership
- Dr. George Magrath CEO, Board Member
- George Magrath CEO, Board Member
- George Magrath, M.D., M.B.A., M.S. CEO, Board Member
- Richard Rodgers CEO, Board Member
- Cam Gallagher Chairman, Board Member
- Nirav Jhaveri CFO
- Rob Gagnon CFO
- Robert Gagnon CFO, Chief Accounting Officer
- Joseph K. Schachle COO
- Joseph Schachle COO
- Amy Rabourn Chief Accounting Officer
- Alan R. Meyer Board Member
- Dr. Adrienne Graves Board Member
- Dr. Benjamin R. Yerxa Board Member
- Dr. James S. Manuso Board Member
- Dr. Jean Bennett Board Member
- James S. Manuso Board Member
- Sean Ainsworth Board Member
- Susan K. Benton Board Member
Key facts
CIK
1228627
CUSIP
67577R102
13F (30d)
23 filings
23 filers
Visit website
Investor relations